Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 3
1998 2
1999 6
2000 2
2001 4
2002 3
2003 9
2004 4
2005 4
2006 12
2007 17
2008 26
2009 27
2010 22
2011 16
2012 13
2013 14
2014 19
2015 16
2016 52
2017 23
2018 29
2019 20
2020 24
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

323 results
Results by year
Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Clinical Trial.
[History of kidney transplantation surgery].
Timsit MO, Kleinclauss F, Thuret R. Timsit MO, et al. Prog Urol. 2016 Nov;26(15):874-881. doi: 10.1016/j.purol.2016.08.003. Epub 2016 Sep 7. Prog Urol. 2016. PMID: 27614385 Review. French.
RESULTS: From the first vascular ligations to the discovery of ciclosporin, the history of organ transplantation was made of surgical bets and medical discoveries, such as blood group, HLA-system, immunity, etc. The audacity of some surgeons led to the onset of renal trans …
RESULTS: From the first vascular ligations to the discovery of ciclosporin, the history of organ transplantation was made of surgical bets a …
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B. Méjean A, et al. Among authors: timsit mo. N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3. N Engl J Med. 2018. PMID: 29860937 Free article. Clinical Trial.
BACKGROUND: Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by randomized trials and large, retrospective studies. ...We assessed the role of nephrectomy in patients with metastatic renal-cell carcin …
BACKGROUND: Cytoreductive nephrectomy has been the standard of care in metastatic renal-cell carcinoma for 20 years, supported by ran …
[French ccAFU guidelines – Update 2018–2020: Bladder cancer].
Rouprêt M, Neuzillet Y, Pignot G, Compérat E, Audenet F, Houédé N, Larré S, Masson-Lecomte A, Colin P, Brunelle S, Xylinas E, Roumiguié M, Méjean A. Rouprêt M, et al. Among authors: mejean a. Prog Urol. 2019 Sep 20;28(S1):R48-R80. doi: 10.1016/j.purol.2019.01.006. Prog Urol. 2019. PMID: 32093463 French.
For metastatic MIBC, first-line chemotherapy using platin is recommended (GC or MVAC), when performans status (PS < 1) and renal function (creatinine clearance > 60 mL/min) allow it (only in 50 % of cases). ...

For metastatic MIBC, first-line chemotherapy using platin is recommended (GC or MVAC), when performans status (PS < 1) and renal f

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
Roumenina LT, Daugan MV, Noé R, Petitprez F, Vano YA, Sanchez-Salas R, Becht E, Meilleroux J, Clec'h BL, Giraldo NA, Merle NS, Sun CM, Verkarre V, Validire P, Selves J, Lacroix L, Delfour O, Vandenberghe I, Thuilliez C, Keddani S, Sakhi IB, Barret E, Ferré P, Corvaïa N, Passioukov A, Chetaille E, Botto M, de Reynies A, Oudard SM, Mejean A, Cathelineau X, Sautès-Fridman C, Fridman WH. Roumenina LT, et al. Among authors: mejean a. Cancer Immunol Res. 2019 Jul;7(7):1091-1105. doi: 10.1158/2326-6066.CIR-18-0891. Epub 2019 Jun 4. Cancer Immunol Res. 2019. PMID: 31164356 Free article.
Clear-cell renal cell carcinoma (ccRCC) possesses an unmet medical need, particularly at the metastatic stage, when surgery is ineffective. ...
Clear-cell renal cell carcinoma (ccRCC) possesses an unmet medical need, particularly at the metastatic stage, when surgery is ineffe …
Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns.
Tordjman M, Dbjay J, Chamouni A, Morini A, Timsit MO, Mejean A, Vasiliu V, Eiss D, Correas JM, Verkarre V, Helenon O. Tordjman M, et al. Among authors: timsit mo, mejean a. AJR Am J Roentgenol. 2020 Mar;214(3):579-587. doi: 10.2214/AJR.19.21681. Epub 2019 Nov 26. AJR Am J Roentgenol. 2020. PMID: 31770020
OBJECTIVE. Clear cell papillary renal cell carcinoma (RCC), an entity with strikingly indolent behavior, recently was added to the World Health Organization classification of renal tumors and represents the fourth most common histologic type of renal cell car …
OBJECTIVE. Clear cell papillary renal cell carcinoma (RCC), an entity with strikingly indolent behavior, recently was added to the Wo …
[French ccAFU guidelines - Update 2018-2020: Management of kidney cancer].
Bensalah K, Albiges L, Bernhard JC, Bigot P, Bodin T, Boissier R, Correas JM, Gimel P, Hetet JF, Long JA, Nouhaud FX, Ouzaïd I, Rioux-Leclercq N, Méjean A. Bensalah K, et al. Among authors: mejean a. Prog Urol. 2018 Nov;28 Suppl 1:R5-R33. doi: 10.1016/j.purol.2019.01.004. Epub 2019 Aug 23. Prog Urol. 2018. PMID: 31610874 French.
OBJECTIVE: To update the French guidelines on kidney cancer. METHODS: A systematic review of the literature between 2015 and 2018 was performed. ...CONCLUSION: These updated recommendations should assist French speaking urologists for their management of kidney canc …
OBJECTIVE: To update the French guidelines on kidney cancer. METHODS: A systematic review of the literature between 2015 and 2018 was …
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, Decaussin-Petrucci M, Dubreuil-Chambardel M, Magaud L, Remontet L, Ruffion A, Colombel M, Crouzet S, Schott AM, Lemaitre L, Rabilloud M, Grenier N; MRI-FIRST Investigators. Rouvière O, et al. Lancet Oncol. 2019 Jan;20(1):100-109. doi: 10.1016/S1470-2045(18)30569-2. Epub 2018 Nov 21. Lancet Oncol. 2019. PMID: 30470502
[French ccAFU guidelines - Update 2018-2020: Upper tract urothelial carcinoma].
Rouprêt M, Xylinas E, Colin P, Houédé N, Compérat E, Audenet F, Larré S, Masson-Lecomte A, Pignot G, Brunelle S, Roumiguié M, Neuzillet Y, Méjean A. Rouprêt M, et al. Among authors: mejean a. Prog Urol. 2018 Nov;28 Suppl 1:R34-R47. doi: 10.1016/j.purol.2019.01.005. Epub 2019 Aug 23. Prog Urol. 2018. PMID: 31610873 French.
[Renal transplantation: Procedure and early follow-up].
Anglicheau D, Tinel C, Canaud G, Loupy A, Zuber J, Delville M, Rabaté C, Scemla A, Snanoudj R, Sberro-Soussan R, Mamzer-Bruneel MF, Bererhi L, Martinez F, Timsit MO, Rabant M, Correas JM, Bienaimé F, Duong JP, Hélénon O, Prié D, Méjean A, Legendre C. Anglicheau D, et al. Among authors: timsit mo, mejean a. Nephrol Ther. 2019 Nov;15(6):469-484. doi: 10.1016/j.nephro.2019.09.001. Epub 2019 Oct 19. Nephrol Ther. 2019. PMID: 31640943 French.
More than fifty years after the success of the two first renal transplantations in Boston and in Necker hospital in Paris, renal transplantation became the treatment of choice of end stage renal failure, because it improves not only the quality of life of the …
More than fifty years after the success of the two first renal transplantations in Boston and in Necker hospital in Paris, renal
323 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback